HUMELTIS has a total of 11 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets measurement and biotechnology are WARREN WILLIAM L, EVOLVA LTD and NCARDIA B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Canada | 1 | |
#3 | China | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | Philippines | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Rapp Judit | 9 |
#2 | Racz Evelin | 5 |
#3 | Pongracz Judit Erzsebet | 4 |
#4 | Rácz Evelin | 4 |
#5 | Pongrácz Judit Erzsébet | 3 |
#6 | Evelin Rácz | 1 |
#7 | Pongracz Judit Erzs‚Bet | 1 |
#8 | Judit Rapp | 1 |
#9 | Judit Erzsébet Pongrácz | 1 |
#10 | Pongrácz Judit | 1 |
Publication | Filing date | Title |
---|---|---|
SG11201808762XA | Diagnostic methods for patient specific therapeutic decision making in cancer care |